|
🐜
|
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
21 auth.
E. Thiel,
A. Korfel,
P. Martus,
L. Kanz,
F. Griesinger,
M. Rauch,
A. Röth,
B. Hertenstein,
Theda von Toll,
T. Hundsberger,
...
H. Mergenthaler,
M. Leithäuser,
T. Birnbaum,
L. Fischer,
K. Jahnke,
U. Herrlinger,
L. Plasswilm,
T. Nägele,
T. Pietsch,
M. Bamberg,
M. Weller
|
9 |
2010 |
9
🐜
|
|
🐜
|
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.
27 auth.
J. Krönke,
R. Schlenk,
Kai-Ole Jensen,
Florian Tschürtz,
A. Corbacioglu,
V. Gaidzik,
P. Paschka,
S. Onken,
Karina Eiwen,
Marianne Habdank,
D. Späth,
M. Lübbert,
M. Wattad,
T. Kindler,
H. Salih,
...
G. Held,
D. Nachbaur,
M. von Lilienfeld-Toal,
U. Germing,
D. Haase,
H. Mergenthaler,
J. Krauter,
A. Ganser,
G. Göhring,
B. Schlegelberger,
H. Döhner,
K. Döhner
|
8 |
2011 |
8
🐜
|
|
🐜
|
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986.
20 auth.
C. Köhne,
E. Cutsem,
J. Wils,
C. Bokemeyer,
M. El-Serafi,
M. Lutz,
M. Lorenz,
P. Reichardt,
H. Rückle-Lanz,
N. Frickhofen,
...
R. Fuchs,
H. Mergenthaler,
T. Langenbuch,
U. Vanhoefer,
P. Rougier,
R. Voigtmann,
L. Müller,
B. Genicot,
Ö. Anak,
B. Nordlinger
|
8 |
2005 |
8
🐜
|
|
🐜
|
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia
26 auth.
R. Schlenk,
S. Fröhling,
F. Hartmann,
J. Fischer,
A. Glasmacher,
F. del Valle,
W. Grimminger,
K. Götze,
C. Waterhouse,
R. Schoch,
H. Pralle,
H. Mergenthaler,
M. Hensel,
E. Koller,
H. Kirchen,
...
J. Preiß,
H. Salwender,
H. Biedermann,
S. Kremers,
F. Griesinger,
A. Benner,
B. Addamo,
K. Döhner,
R. Haas,
H. Döhner,
for the Aml Study Group Ulm
|
7 |
2004 |
7
🐜
|
|
🐜
|
German Cancer Society Neuro‐Oncology Working Group NOA‐03 multicenter trial of single‐agent high‐dose methotrexate for primary central nervous system lymphoma
17 auth.
U. Herrlinger,
M. Schabet,
W. Brugger,
R. Kortmann,
W. Küker,
M. Deckert,
C. Engel,
H. Schmeck-Lindenau,
H. Mergenthaler,
P. Krauseneck,
...
C. Benöhr,
C. Meisner,
O. Wiestler,
J. Dichgans,
L. Kanz,
M. Bamberg,
M. Weller
|
7 |
2002 |
7
🐜
|
|
🐜
|
Whole body positron emission tomography in the treatment of Hodgkin disease
7 auth.
Beatrix Hueltenschmidt,
M. Sautter‐Bihl,
O. Lang,
F. Maul,
J. Fischer,
H. Mergenthaler,
...
H. Bihl
|
7 |
2001 |
7
🐜
|
|
🐜
|
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma
20 auth.
A. Korfel,
E. Thiel,
P. Martus,
R. Möhle,
F. Griesinger,
M. Rauch,
A. Röth,
B. Hertenstein,
T. Fischer,
T. Hundsberger,
...
H. Mergenthaler,
C. Junghanss,
T. Birnbaum,
L. Fischer,
K. Jahnke,
U. Herrlinger,
P. Roth,
M. Bamberg,
T. Pietsch,
M. Weller
|
6 |
2015 |
6
🐜
|
|
🐜
|
VLA‐4 and VCAM‐1 are the principal adhesion molecules involved in the interaction between blast colony‐forming cells and bone marrow stromal cells
7 auth.
R. Oostendorp,
G. Reisbach,
E. Spitzer,
K. Thalmeier,
Hendrik Dienemann,
H. Mergenthaler,
...
P. Dörmer
|
6 |
1995 |
6
🐜
|
|
🐜
|
Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
25 auth.
M. Pfreundschuh,
M. Kloess,
R. Schmits,
S. Zeynalova,
E. Lengfelder,
A. Franke,
H. Steinhauer,
M. Reiser,
M. Clemens,
C. Nickenig,
M. D. Wit,
M. Hoffmann,
R. Mertelsmann,
B. Metzner,
A. Ho,
...
L. Truemper,
H. Eimermacher,
H. Mergenthaler,
R. Liersch,
U. Duehrsen,
L. Balleisen,
F. Hartmann,
V. Poeschel,
N. Schmitz,
M. Loeffler
|
6 |
2005 |
6
🐜
|
|
🐜
|
131I-cG250 monoclonal antibody immunoscintigraphy versus [18F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study
10 auth.
A. Brouwers,
U. Dorr,
O. Lang,
O. Boerman,
W. Oyen,
M. Steffens,
...
E. Oosterwijk,
H. Mergenthaler,
H. Bihl,
F. Corstens
|
5 |
2002 |
5
🐜
|
|
🐜
|
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.
20 auth.
A. Korfel,
M. Weller,
P. Martus,
P. Roth,
H. Klasen,
A. Roeth,
M. Rauch,
B. Hertenstein,
T. Fischer,
T. Hundsberger,
...
M. Leithäuser,
T. Birnbaum,
H. Kirchen,
H. Mergenthaler,
J. Schubert,
Wolfgang E. Berdel,
J. Birkmann,
M. Hummel,
E. Thiel,
L. Fischer
|
5 |
2012 |
5
🐜
|
